{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:16:23Z","timestamp":1790046983130,"version":"4.0.1"},"reference-count":108,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T00:00:00Z","timestamp":1538265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>AMP-activated protein kinase (AMPK) is a heterotrimeric serine\/threonine kinase consisting of the arrangement of various \u03b1 \u03b2, and \u03b3 isoforms that are expressed differently depending on the tissue or the cell lineage. AMPK is one of the major sensors of energy status in mammalian cells and as such plays essential roles in the regulation of cellular homeostasis, metabolism, cell growth, differentiation, apoptosis, and autophagy. AMPK is activated by two upstream kinases, the tumor suppressor liver kinase B1 (LKB1) and the calcium\/calmodulin-dependent protein kinase kinase 2 (CAMKK2) through phosphorylation of the kinase on Thr172, leading to its activation. In addition, AMPK inhibits the mTOR pathway through phosphorylation and activation of tuberous sclerosis protein 2 (TSC2) and causes direct activation of unc-51-like autophagy activating kinase 1 (ULK1) via phosphorylation of Ser555, thus promoting initiation of autophagy. Although it is well established that AMPK can control the differentiation of different cell lineages, including hematopoietic stem cells (HSCs), progenitors, and mature hematopoietic cells, the role of AMPK regarding myeloid cell differentiation is less documented. The differentiation of monocytes into macrophages triggered by colony stimulating factor 1 (CSF-1), a process during which both caspase activation (independently of apoptosis induction) and AMPK-dependent stimulation of autophagy are necessary, is one noticeable example of the involvement of AMPK in the physiological differentiation of myeloid cells. The present review focuses on the role of AMPK in the regulation of the physiological and pathological differentiation of myeloid cells. The mechanisms of autophagy induction by AMPK will also be addressed, as autophagy has been shown to be important for differentiation of hematopoietic cells. In addition, myeloid malignancies (myeloid leukemia or dysplasia) are characterized by profound defects in the establishment of proper differentiation programs. Reinduction of a normal differentiation process in myeloid malignancies has thus emerged as a valuable and promising therapeutic strategy. As AMPK seems to exert a key role in the differentiation of myeloid cells, notably through induction of autophagy, we will also discuss the potential to target this pathway as a pro-differentiating and anti-leukemic strategy in myeloid malignancies.<\/jats:p>","DOI":"10.3390\/ijms19102991","type":"journal-article","created":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T08:23:50Z","timestamp":1538468630000},"page":"2991","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Implication and Regulation of AMPK during Physiological and Pathological Myeloid Differentiation"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5062-8048","authenticated-orcid":false,"given":"Arnaud","family":"Jacquel","sequence":"first","affiliation":[{"name":"Universit\u00e9 C\u00f4te d\u2019Azur, C3M Inserm U1065, 06204 Nice, France"},{"name":"Equipe Labellis\u00e9e par la Fondation ARC, 94803 Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9253-4998","authenticated-orcid":false,"given":"Frederic","family":"Luciano","sequence":"additional","affiliation":[{"name":"Universit\u00e9 C\u00f4te d\u2019Azur, C3M Inserm U1065, 06204 Nice, France"},{"name":"Equipe Labellis\u00e9e par la Fondation ARC, 94803 Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Robert","sequence":"additional","affiliation":[{"name":"Universit\u00e9 C\u00f4te d\u2019Azur, C3M Inserm U1065, 06204 Nice, France"},{"name":"Equipe Labellis\u00e9e par la Fondation ARC, 94803 Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2481-8275","authenticated-orcid":false,"given":"Patrick","family":"Auberger","sequence":"additional","affiliation":[{"name":"Universit\u00e9 C\u00f4te d\u2019Azur, C3M Inserm U1065, 06204 Nice, France"},{"name":"Equipe Labellis\u00e9e par la Fondation ARC, 94803 Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,9,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cmet.2017.10.009","article-title":"AMPK: Sensing Glucose as well as Cellular Energy Status","volume":"27","author":"Lin","year":"2018","journal-title":"Cell Metab."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ceb.2014.09.004","article-title":"AMPK: Positive and negative regulation, and its role in whole-body energy homeostasis","volume":"33","author":"Hardie","year":"2015","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.tcb.2015.10.013","article-title":"AMPK: An Energy-Sensing Pathway with Multiple Inputs and Outputs","volume":"26","author":"Hardie","year":"2016","journal-title":"Trends Cell Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1101\/gad.17420111","article-title":"AMP-activated protein kinase: An energy sensor that regulates all aspects of cell function","volume":"25","author":"Hardie","year":"2011","journal-title":"Genes Dev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1152\/physrev.00011.2008","article-title":"AMPK in Health and Disease","volume":"89","author":"Steinberg","year":"2009","journal-title":"Physiol. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1113\/JP270543","article-title":"Calorie restriction as an intervention in ageing","volume":"594","author":"Navas","year":"2016","journal-title":"J. Physiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.celrep.2018.02.024","article-title":"Aspirin Recapitulates Features of Caloric Restriction","volume":"22","author":"Pietrocola","year":"2018","journal-title":"Cell Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ccell.2016.05.016","article-title":"Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance","volume":"30","author":"Pietrocola","year":"2016","journal-title":"Cancer Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.4161\/auto.36413","article-title":"Caloric restriction mimetics: Natural\/physiological pharmacological autophagy inducers","volume":"10","author":"Marino","year":"2014","journal-title":"Autophagy"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1158\/1535-7163.MCT-09-1186","article-title":"Metformin in cancer therapy: A new perspective for an old antidiabetic drug?","volume":"9","author":"Tanti","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.cell.2008.06.051","article-title":"AMPK and PPARdelta agonists are exercise mimetics","volume":"134","author":"Narkar","year":"2008","journal-title":"Cell"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Robert, G., Ben Sahra, I., Puissant, A., Colosetti, P., Belhacene, N., Gounon, P., Hofman, P., Bost, F., Cassuto, J.P., and Auberger, P. (2009). Acadesine kills chronic myelogenous leukemia (CML) cells through PKC-dependent induction of autophagic cell death. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0007889"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1182\/blood-2002-07-2339","article-title":"Acadesine activates AMPK and induces apoptosis in B-cell chronic lymphocytic leukemia cells but not in T lymphocytes","volume":"101","author":"Campas","year":"2003","journal-title":"Blood"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"12932","DOI":"10.1073\/pnas.0906606106","article-title":"The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis","volume":"106","author":"Guo","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1158\/1535-7163.MCT-06-0800","article-title":"5-Aminoimidazole-4-carboxamide riboside sensitizes TRAIL- and TNF\u03b1-induced cytotoxicity in colon cancer cells through AMP-activated protein kinase signaling","volume":"6","author":"Su","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ncb2329","article-title":"The AMPK signalling pathway coordinates cell growth, autophagy and metabolism","volume":"13","author":"Mihaylova","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cmet.2016.02.017","article-title":"AMPK Promotes Autophagy by Facilitating Mitochondrial Fission","volume":"23","author":"Zhang","year":"2016","journal-title":"Cell Metab."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrm.2017.95","article-title":"AMPK: Guardian of metabolism and mitochondrial homeostasis","volume":"19","author":"Herzig","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.cub.2007.08.047","article-title":"An AMPK-FOXO pathway mediates longevity induced by a novel method of dietary restriction in C. elegans","volume":"17","author":"Greer","year":"2007","journal-title":"Curr. Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nature09706","article-title":"Lifespan extension induced by AMPK and calcineurin is mediated by CRTC-1 and CREB","volume":"470","author":"Mair","year":"2011","journal-title":"Nature"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.cmet.2017.09.024","article-title":"Dietary Restriction and AMPK Increase Lifespan via Mitochondrial Network and Peroxisome Remodeling","volume":"26","author":"Weir","year":"2017","journal-title":"Cell Metab."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1083\/jcb.201707168","article-title":"Regulation of reproduction and longevity by nutrient-sensing pathways","volume":"217","author":"Templeman","year":"2018","journal-title":"J. Cell Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.molcel.2011.11.005","article-title":"Chemical genetic screen for AMPKalpha2 substrates uncovers a network of proteins involved in mitosis","volume":"44","author":"Banko","year":"2011","journal-title":"Mol. Cell"},{"key":"ref_24","first-page":"299","article-title":"Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise","volume":"270","author":"Winder","year":"1996","journal-title":"Am. J. Physiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncb2152","article-title":"AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1","volume":"13","author":"Kim","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cmet.2011.01.009","article-title":"AMPK-dependent phosphorylation of ULK1 induces autophagy","volume":"13","author":"Zhao","year":"2011","journal-title":"Cell Metab."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41467-017-00520-9","article-title":"Ampk phosphorylation of Ulk1 is required for targeting of mitochondria to lysosomes in exercise-induced mitophagy","volume":"8","author":"Laker","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1042\/BJ20131344","article-title":"Phosphorylation by Akt within the ST loop of AMPK-alpha1 down-regulates its activation in tumour cells","volume":"459","author":"Hawley","year":"2014","journal-title":"Biochem. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","article-title":"AKT\/PKB Signaling: Navigating the Network","volume":"169","author":"Manning","year":"2017","journal-title":"Cell"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.cmet.2013.09.005","article-title":"AMP as a low-energy charge signal autonomously initiates assembly of AXIN-AMPK-LKB1 complex for AMPK activation","volume":"18","author":"Zhang","year":"2013","journal-title":"Cell Metab."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.cmet.2014.06.014","article-title":"The lysosomal v-ATPase-Ragulator complex is a common activator for AMPK and mTORC1, acting as a switch between catabolism and anabolism","volume":"20","author":"Zhang","year":"2014","journal-title":"Cell Metab."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature11862","article-title":"Metabolism of inflammation limited by AMPK and pseudo-starvation","volume":"493","author":"Hardie","year":"2013","journal-title":"Nature"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.2337\/db15-0107","article-title":"AMPK Suppresses Vascular Inflammation In Vivo by Inhibiting Signal Transducer and Activator of Transcription-1","volume":"64","author":"He","year":"2015","journal-title":"Diabetes"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.12688\/f1000research.11960.1","article-title":"AMP-activated protein kinase\u2014Not just an energy sensor","volume":"6","author":"Hardie","year":"2017","journal-title":"F1000Reseach"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.bcp.2018.01.049","article-title":"Promise and challenges for direct small molecule AMPK activators","volume":"153","author":"Olivier","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1042\/BJ20150910","article-title":"Differential regulation by AMP and ADP of AMPK complexes containing different gamma subunit isoforms","volume":"473","author":"Ross","year":"2016","journal-title":"Biochem. J."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Neumann, D. (2018). Is TAK1 a Direct Upstream Kinase of AMPK?. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19082412"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1042\/BJ20120546","article-title":"AMP-activated protein kinase: New regulation, new roles?","volume":"445","author":"Carling","year":"2012","journal-title":"Biochem. J."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.cmet.2015.09.009","article-title":"Identification of AMPK Phosphorylation Sites Reveals a Network of Proteins Involved in Cell Invasion and Facilitates Large-Scale Substrate Prediction","volume":"22","author":"Schaffer","year":"2015","journal-title":"Cell Metab."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41586-018-0350-5","article-title":"Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer","volume":"559","author":"Wu","year":"2018","journal-title":"Nature"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nature09571","article-title":"Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells","volume":"468","author":"Nakada","year":"2010","journal-title":"Nature"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nature09595","article-title":"Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cells","volume":"468","author":"Gan","year":"2010","journal-title":"Nature"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"643","DOI":"10.4161\/auto.7.6.15123","article-title":"The autophagy initiating kinase ULK1 is regulated via opposing phosphorylation by AMPK and mTOR","volume":"7","author":"Egan","year":"2011","journal-title":"Autophagy"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.stem.2012.11.022","article-title":"Metabolic regulation by the mitochondrial phosphatase PTPMT1 is required for hematopoietic stem cell differentiation","volume":"12","author":"Yu","year":"2013","journal-title":"Cell Stem Cell"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"12017","DOI":"10.1073\/pnas.0705070104","article-title":"AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha","volume":"104","author":"Jager","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nri3671","article-title":"Monocytes and macrophages: Developmental pathways and tissue homeostasis","volume":"14","author":"Ginhoux","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nri.2017.28","article-title":"Monocyte differentiation and antigen-presenting functions","volume":"17","author":"Jakubzick","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1182\/blood-2002-06-1778","article-title":"Specific involvement of caspases in the differentiation of monocytes into macrophages","volume":"100","author":"Sordet","year":"2002","journal-title":"Blood"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Stanley, E.R., and Chitu, V. (2014). CSF-1 receptor signaling in myeloid cells. Cold Spring Harb. Perspect. Biol., 6.","DOI":"10.1101\/cshperspect.a021857"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1182\/blood-2011-11-392167","article-title":"Autophagy is required for CSF-1-induced macrophagic differentiation and acquisition of phagocytic functions","volume":"119","author":"Jacquel","year":"2012","journal-title":"Blood"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1080\/15548627.2015.1034406","article-title":"The PRKAA1\/AMPKalpha1 pathway triggers autophagy during CSF1-induced human monocyte differentiation and is a potential target in CMML","volume":"11","author":"Obba","year":"2015","journal-title":"Autophagy"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1182\/blood-2006-03-011585","article-title":"Caspase-8 prevents sustained activation of NF-kappaB in monocytes undergoing macrophagic differentiation","volume":"109","author":"Rebe","year":"2007","journal-title":"Blood"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1182\/blood-2009-03-208843","article-title":"Colony-stimulating factor-1-induced oscillations in phosphatidylinositol-3 kinase\/AKT are required for caspase activation in monocytes undergoing differentiation into macrophages","volume":"114","author":"Jacquel","year":"2009","journal-title":"Blood"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.leukres.2017.06.007","article-title":"Autophagy is an important event for low-dose cytarabine treatment in acute myeloid leukemia cells","volume":"60","author":"Chen","year":"2017","journal-title":"Leuk. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"7888","DOI":"10.1074\/jbc.M117.779447","article-title":"AMP-activated protein kinase alpha1 promotes atherogenesis by increasing monocyte-to-macrophage differentiation","volume":"292","author":"Zhang","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"32771","DOI":"10.1038\/srep32771","article-title":"Functional differences between AMPK alpha1 and alpha2 subunits in osteogenesis, osteoblast-associated induction of osteoclastogenesis, and adipogenesis","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1476-4598-6-46","article-title":"Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: Implication for targeted therapy","volume":"6","author":"Sengupta","year":"2007","journal-title":"Mol. Cancer"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.18632\/oncotarget.413","article-title":"AMPK in BCR-ABL expressing leukemias. Regulatory effects and therapeutic implications","volume":"2","author":"Vakana","year":"2011","journal-title":"Oncotarget"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/leu.2008.348","article-title":"Stabilization and activation of p53 downregulates mTOR signaling through AMPK in mantle cell lymphoma","volume":"23","author":"Drakos","year":"2009","journal-title":"Leukemia"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"6399","DOI":"10.1182\/blood-2011-01-332783","article-title":"Antileukemic effects of AMPK activators on BCR-ABL-expressing cells","volume":"118","author":"Vakana","year":"2011","journal-title":"Blood"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/ejh.13092","article-title":"The genetic and molecular pathogenesis of myelodysplastic syndromes","volume":"101","author":"Shallis","year":"2018","journal-title":"Eur. J. Haematol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1470-2045(09)70003-8","article-title":"Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: A randomised, open-label, phase III study","volume":"10","author":"Fenaux","year":"2009","journal-title":"Lancet Oncol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1182\/blood-2006-05-021162","article-title":"Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia","volume":"109","author":"Kantarjian","year":"2007","journal-title":"Blood"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1200\/JCO.2008.19.6550","article-title":"Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: The alternative dosing for outpatient treatment (ADOPT) trial","volume":"27","author":"Steensma","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrm3311","article-title":"AMPK: A nutrient and energy sensor that maintains energy homeostasis","volume":"13","author":"Hardie","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.4161\/cc.10.14.16308","article-title":"Azacitidine-resistant SKM1 myeloid cells are defective for AZA-induced mitochondrial apoptosis and autophagy","volume":"10","author":"Cluzeau","year":"2011","journal-title":"Cell Cycle"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"490","DOI":"10.18632\/oncotarget.481","article-title":"BCL2L10 is a predictive factor for resistance to azacitidine in MDS and AML patients","volume":"3","author":"Cluzeau","year":"2012","journal-title":"Oncotarget"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/leu.2014.331","article-title":"Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells","volume":"29","author":"Dolatshad","year":"2015","journal-title":"Leukemia"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.stem.2015.08.019","article-title":"AMPK Protects Leukemia-Initiating Cells in Myeloid Leukemias from Metabolic Stress in the Bone Marrow","volume":"17","author":"Saito","year":"2015","journal-title":"Cell Stem Cell"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.exphem.2015.03.005","article-title":"Negative regulation of the LKB1\/AMPK pathway by ERK in human acute myeloid leukemia cells","volume":"43","author":"Kawashima","year":"2015","journal-title":"Exp. Hematol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1182\/blood-2010-02-269837","article-title":"The LKB1\/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation","volume":"116","author":"Green","year":"2010","journal-title":"Blood"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.celrep.2015.04.063","article-title":"Co-activation of AMPK and mTORC1 Induces Cytotoxicity in Acute Myeloid Leukemia","volume":"11","author":"Sujobert","year":"2015","journal-title":"Cell Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199904293401706","article-title":"Chronic myeloid leukemia","volume":"340","author":"Sawyers","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nrc1567","article-title":"Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia","volume":"5","author":"Ren","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.leu.2403241","article-title":"JAK\/STAT, Raf\/MEK\/ERK, PI3K\/Akt and BCR-ABL in cell cycle progression and leukemogenesis","volume":"18","author":"Steelman","year":"2004","journal-title":"Leukemia"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1182\/blood-2004-03-0849","article-title":"Activation of the PI3K\/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen species","volume":"105","author":"Kim","year":"2005","journal-title":"Blood"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/10428194.2010.546919","article-title":"Regulation of mammalian target of rapamycin and mitogen activated protein kinase pathways by BCR-ABL","volume":"52","author":"Redig","year":"2011","journal-title":"Leuk. Lymphoma"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/sj.leu.2403006","article-title":"Randomized comparison of interferon alpha and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): Prolongation of survival by the combination of interferon alpha and hydroxyurea","volume":"17","author":"Hehlmann","year":"2003","journal-title":"Leukemia"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Druker","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1182\/blood.V96.6.2246","article-title":"CGP57148B (STI-571) induces differentiation and apoptosis and sensitizes Bcr-Abl-positive human leukemia cells to apoptosis due to antileukemic drugs","volume":"96","author":"Fang","year":"2000","journal-title":"Blood"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/sj.cdd.4400400","article-title":"Selective induction of apoptosis in Philadelphia chromosome-positive chronic myelogenous leukemia cells by an inhibitor of BCR\u2014ABL tyrosine kinase, CGP 57148","volume":"5","author":"Dan","year":"1998","journal-title":"Cell Death Differ."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.leukres.2017.01.005","article-title":"Current approach to the treatment of chronic myeloid leukaemia","volume":"55","author":"Pasic","year":"2017","journal-title":"Leuk. Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.hoc.2017.04.007","article-title":"Mechanisms of Resistance to ABL Kinase Inhibition in Chronic Myeloid Leukemia and the Development of Next Generation ABL Kinase Inhibitors","volume":"31","author":"Patel","year":"2017","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12943-018-0780-6","article-title":"Chronic myeloid leukemia: The paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy","volume":"17","author":"Soverini","year":"2018","journal-title":"Mol. Cancer"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1182\/blood.V101.2.690","article-title":"BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571","volume":"101","author":"Donato","year":"2003","journal-title":"Blood"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bcmd.2013.09.002","article-title":"Expression of LYN and PTEN genes in chronic myeloid leukemia and their importance in therapeutic strategy","volume":"52","author":"Ferri","year":"2014","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1158\/1535-7163.MCT-09-0168","article-title":"Gene expression profiling of imatinib and PD166326-resistant CML cell lines identifies Fyn as a gene associated with resistance to BCR-ABL inhibitors","volume":"8","author":"Grosso","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.cell.2006.06.055","article-title":"TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth","volume":"126","author":"Inoki","year":"2006","journal-title":"Cell"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","article-title":"AMPK phosphorylation of raptor mediates a metabolic checkpoint","volume":"30","author":"Gwinn","year":"2008","journal-title":"Mol. Cell"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1096\/fj.07-101394","article-title":"Imatinib mesylate-resistant human chronic myelogenous leukemia cell lines exhibit high sensitivity to the phytoalexin resveratrol","volume":"22","author":"Puissant","year":"2008","journal-title":"FASEB J."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1158\/0008-5472.CAN-09-3537","article-title":"Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62\/SQSTM1 expression and AMPK activation","volume":"70","author":"Puissant","year":"2010","journal-title":"Cancer Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/CAD.0000000000000266","article-title":"The antileukemia effect of metformin in the Philadelphia chromosome-positive leukemia cell line and patient primary leukemia cell","volume":"26","author":"Shi","year":"2015","journal-title":"Anticancer Drugs"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/ajh.25104","article-title":"Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management","volume":"93","author":"Patnaik","year":"2018","journal-title":"Am. J. Hematol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1182\/blood-2017-04-779579","article-title":"Accumulation of classical monocytes defines a subgroup of MDS that frequently evolves into CMML","volume":"130","author":"Badaoui","year":"2017","journal-title":"Blood"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1182\/blood-2009-05-224352","article-title":"Alpha-defensins secreted by dysplastic granulocytes inhibit the differentiation of monocytes in chronic myelomonocytic leukemia","volume":"115","author":"Droin","year":"2010","journal-title":"Blood"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s12185-017-2243-z","article-title":"CMML: Clinical and molecular aspects","volume":"105","author":"Itzykson","year":"2017","journal-title":"Int. J. Hematol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.leukres.2013.01.004","article-title":"Predictive factors of response and survival among chronic myelomonocytic leukemia patients treated with azacitidine","volume":"37","author":"Ades","year":"2013","journal-title":"Leuk. Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3109\/10428194.2012.719617","article-title":"High rate of remissions in chronic myelomonocytic leukemia treated with 5-azacytidine: Results of an Italian retrospective study","volume":"54","author":"Fianchi","year":"2013","journal-title":"Leuk. Lymphoma"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.leukres.2007.08.004","article-title":"Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML)","volume":"32","author":"Wijermans","year":"2008","journal-title":"Leuk. Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1038\/leu.2017.159","article-title":"A phase 1b\/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with 30% blasts","volume":"31","author":"Sekeres","year":"2017","journal-title":"Leukemia"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s12185-017-2327-9","article-title":"Phase I study of panobinostat and 5-azacitidine in Japanese patients with myelodysplastic syndrome or chronic myelomonocytic leukemia","volume":"107","author":"Kobayashi","year":"2018","journal-title":"Int. J. Hematol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.4161\/cc.9.17.13048","article-title":"Targeting autophagy to fight hematopoietic malignancies","volume":"9","author":"Puissant","year":"2010","journal-title":"Cell Cycle"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1182\/blood-2010-05-283960","article-title":"AICAR induces apoptosis independently of AMPK and p53 through up-regulation of the BH3-only proteins BIM and NOXA in chronic lymphocytic leukemia cells","volume":"116","author":"Santidrian","year":"2010","journal-title":"Blood"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00280-012-2033-5","article-title":"Acadesine for patients with relapsed\/refractory chronic lymphocytic leukemia (CLL): A multicenter phase I\/II study","volume":"71","author":"Cazin","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1038\/emm.2016.16","article-title":"AMPK activators: Mechanisms of action and physiological activities","volume":"48","author":"Kim","year":"2016","journal-title":"Exp. Mol. Med."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/febs.13962","article-title":"Mechanistic roles of autophagy in hematopoietic differentiation","volume":"284","author":"Riffelmacher","year":"2017","journal-title":"FEBS J."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/10\/2991\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:23:24Z","timestamp":1760196204000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/10\/2991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,30]]},"references-count":108,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,10]]}},"alternative-id":["ijms19102991"],"URL":"https:\/\/doi.org\/10.3390\/ijms19102991","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,30]]}}}